{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:55:02Z","timestamp":1648958102612},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1998]]},"DOI":"10.2165\/00002018-199819040-00003","type":"journal-article","created":{"date-parts":[[2006,1,21]],"date-time":"2006-01-21T10:01:14Z","timestamp":1137837674000},"page":"269-282","source":"Crossref","is-referenced-by-count":19,"title":["A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer"],"prefix":"10.2165","volume":"19","author":[{"given":"Yves","family":"Beguin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:18:15Z","timestamp":1455027495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199819040-00003"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199819040-00003","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}